MTOR and gastric cancer: Since metformin alone or combination with cisplatin could not totally decrease proliferation of gastric cancer cells as determined by a relatively high expression of p-mTOR and p4EBP1, synchronous inhibition of mTOR signaling may be important for improving treatment efficiency in gastric cancer.